Jerry Cheng, M.D.
Cheng works with a team of oncologists, pharmacists, nurse coordinators, pediatric nurses, social workers and medical assistants to provide the best care possible. He says that good communication is essential to their success. Cheng believes in treating the whole patient, not just the disease, and says that to him, mind, body and spirit are one.
Cheng went to medical school at University of California, Irvine and completed his pediatric residency and internship at UCLA Medical Center. His fellowship in pediatric hematology/oncology was also completed at the same institution.
Born and raised in Oahu, Hawaii, Cheng left the island life behind him after high school, though he still returns annually to enjoy the nice weather and kind people. When he’s not at work, he enjoys spending time with his family, exercising and playing golf.
1996, B.S. Molecular and Cell Biology, honors, magna cum laude, University of California, Berkeley, CA
2001, M.D., University of California at San Diego, School of Medicine, San Diego, CA
2004-2007, Pediatric Hematology-Oncology, Mattel Children's Hospital at UCLA, Los Angeles, CA
2002-2004, Pediatrics, Mattel Children's Hospital at UCLA, Los Angeles, CA
2001-2002, Pediatrics, Mattel Children's Hospital at UCLA, Los Angeles, CA
2014-Present, Staff Physician, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
2017, Assistant Clinical Professor, David Geffen School of Medicine at UCLA, Los Angeles, CA
2016, Advisory Council – Chair for 2016, Kaiser Permanente National Transplant Services
2013-Present, Bone Marrow Transplant Section, Chair, Kaiser Permanente National Transplant Services
2009-Present, Co-principal Investigator for Children’s Oncology Group, Kaiser Permanente Southern California Medical Group
2009-Present, Pediatric Bone Marrow Transplant Director, Kaiser Permanente Southern California Medical Group
2007-Present, Staff Pediatric Hematologist-Oncologist, Kaiser Permanente Los Angeles Medical Center
2007-Present, Clinical Instructor in Pediatrics, David Geffen School of Medicine at UCLA
2007-Present, American Society of Pediatric Hematology-Oncology
2005-Present, American Society of Blood and Marrow Transplantation
2005-Present, American Board of Pediatrics
2004-Present, American Society of Hematology
- Breckler, J., Cheng, J., Au, K., and Burnside, B. “Novel Myosin VI Isoforms Are Abundantly Expressed in Retina.” Experimental Eye Research Jan. 2000 (70): 121-134.
- Mora-Garcia, P., Cheng, J., Crans-Vargas, HN., Countouriotis, A., and Sakamoto, K. Transcriptional Regulators and Myelopoiesis: The Role of SRF and CREB as Targets of Cytokine Signaling. Stem Cells. 2003; 21:123-130.
- Cheng, J. Tick Paralysis Case Report. Peds in Review 8/03.
- Kanegaye, J., Cheng, J., McCaslin, I., Trocinski, D., and Silva, T. Improved Documentation of Wound Care With a Structured Encounter Form in the Pediatric Emergency Department. Ambulatory Pediatrics July-August 2005; 5(4): 253- 257.
- Cheng, J., Moore, T.B., and Sakamoto, K., RNA Interference and Human Disease. Molecular Genetics and Metabolism, 2003 Sep-Oct;80(1-2): 121-8.
- Shankar, D.B., Cheng, J., Wang, J., Pan, R., Countouriotis, A., Federman, N., Gill, A., Rao, N.P., Moore, T., and Sakamoto, K.M. “The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia.” Cancer Cell, 7:351-362, 2005.
- Cheng, J., Esparza, S., Sakamoto, K., and Moore, T.B. Severe Lactic Acidosis in a Fourteen Year-old Female with Metastatic Undifferentiated Carcinoma of Unknown Primary. Journal of Pediatric Hematology-Oncology, October 2004.
- Cheng, J. and Sakamoto, K. “The Emerging Role of RNA Interference in the Design of Novel Therapeutics in Oncology.” October, Cell Cycle, 2004.
- Cheng, J., and Sakamoto, K.M. “Management of Pediatric Acute Myeloid Leukemia” Medscape General Medicine: Topics in Pediatric Leukemia (www.medscape.com).
- Shankar, D., Cheng, J.C., and Sakamoto, K.M. The Role of Cyclic AMP Response Element Binding Protein in Human Leukemias. Invited Review, Cancer, Sep 29, 2005.
- Cheng, J.C., Sakamoto, K.M., Horwitz, E.M., Karsten, S.L., Shoemaker, L., Kornblum, H.I., and Malik, P. A Meeting Report: “New Technologies in Stem Cell Research.” Stem Cells, Jan 25, 2007.
- Cheng, J.C., Esparza, S.E., and Sakamoto, K.M. “Potential role of CREB as a prognostic marker in acute myeloid leukemia.” Future Oncology, Aug. 2007;3(4):475-80.
- Cheng, J.C., Kinjo, K., Wu, Winston., et al., “CREB is a critical regulator of normal hematopoiesis and leukemogenesis.” Blood, Feb. 1, 2008; 111(3):1182-92.
- Pellegrini, M., Cheng, J.C., Sakamoto, K.M., et al., “Expression Profile of CREB knockdown in Myeloid Leukemia Cells.” BMC Cancer, 2008, 8:264.
- Solis O.E., Mehta R.I., Lai A, Mehta R.I., Farchoukh L.O., Green R.M., Cheng J.C., Natarajan S, Vinters H.V., Cloughesy T, and Yong W.H. “Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases.” J NeuroOncology, Sep 25, 2010.
- Tidwell, T., Weschler, J., Ramesh, C., Trump, L., Salipante, S., Cheng, J.C., et al. Neutropenia-associated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoforms. Blood. November 1, 2013.
- Epstein, Joel B, Raber-Durlacher, JE, Huysmans, MC, Schoordijk, M., Cheng, J.C., Bensadoun RJ, and Arany, P. Photobiomodulation therapy alleviates tissue fibroses associated with graft-versus-host disease: literature review and case reports. Photomedicine and Laser Surgery. Submitted March 2017.